DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy
Applying to AHN Cancer Institute - Allegheny General · Pittsburgh, Pennsylvania
Answer a few short questions to share with the research team.